|
|
| Short Contents | Full Contents | Other books NCBI |
|
|
AHRQ Evidence reports and summaries  AHRQ Evidence Reports, Numbers 61 - 11964. S-Adenosyl-L-Methionine for Treatment of Depression, Osteoarthritis, and Liver Disease Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 2101 East Jefferson Street Rockville, MD 20852 Contract No. 290-97-0001 Prepared by: Southern California Evidence-Based Practice Center Mary Hardy, M.D. Principal Investigator Ian Coulter, Ph.D. Sally C. Morton, Ph.D. Joya Favreau, M.D. Swamy Venuturupalli, M.D. Francesco Chiappelli, Ph.D. Frederico Rossi, M.D. Greg Orshansky, MD Lara K. Jungvig, B.A. Elizabeth A. Roth, M.A. Marika J. Suttorp, M.S. Paul Shekelle, M.D., Ph.D. Investigators AHRQ Publication No. 02-E034 October 2002 ISBN: 1-58763-122-9 ISSN: 1530-4396 This report may be used, in whole or in part, as the basis for development of clinical practice guidelines and other quality enhancement tools, or as a basis for reimbursement and coverage policies. Endorsement by the Agency for Healthcare Research and Quality (AHRQ) or the U.S. Department of Health and Human Services (DHHS) of such derivative products may not be stated or implied. AHRQ is the lead Federal agency charged with supporting research designed to improve the quality of health care, reduce its cost, address patient safety and medical errors, and broaden access to essential services. AHRQ sponsors and conducts research that provides evidence-based information on health care outcomes; quality; and cost, use, and access. The information helps heath care decisionmakers |
patients and clinicians, health system leaders, and policymakers